Cpl Life Sciences US

US Staffing within Life Sciences

Close
  • Job Search
    • Physicians
    • Clinical Research
    • Regulatory Affairs
    • Send us your Resume
  • About Us
    • Meet The Team
    • Testimonials
    • Press
    • Contact Us
  • Industry Training
  • Client Services
    • Testimonials
  • Case Studies
  • My Account
Menu

achillion

Written by Cpl Life Sciences US
October 18, 2019

Boston firm, Alexion acquires Achillion for $930 million

Achillion Pharmaceuticals Inc. has been purchased by Alexion Pharmaceuticals Inc. of Boston for $930 million, or $6.30 a share, pending approval by Achillion shareholders and regulators. Achillion shareholders will also get an extra dollar a share if the FDA approves Achillion’s Danicopan (for a rare blood disease) and another dollar if a drug in development

Continue Reading

Categories

  • Uncategorized
  • News
  • Career Advice
  • Company Info
  • Industry news

Tags

Abbvie achillion acquisitions advertising Alexion Allergan AstraZeneca Biosimilar Biotech BMS Boston Breast Cancer Brexit clinical research Clinical Trial clinical trials CMO Conference CPL Physicians drug development Elections Eli Lilly FDA Gene therapy Gilead graduate academy Health Hep C immuno-oncology J&J JnJ Networking Novartis Novo Nordisk oncology Parexel Pfizer Pharmaceutical Regulatory Roche Sandoz Sanofi Takeda UK US

Like to Talk to a Consultant?

Call or email us directly and find out your next career step:
info@cplphysicians.com or (617) 844-1434



Part of the Cpl Group

Expert Life Science Staffing

Contact Us

Call or email us to find out how we can assist you today

Call Us

Email Us

Our Offices

HEADQUARTERS
Cambridge, Boston,
Call: (617) 844-1434

UK
T: +44 (0)118 9522 799
BELGIUM
T: +32 (0)2 892 3993
GERMANY
T: +49 (0)711 222 54 403
IRELAND
T: +353 (0)144 752 96

© 2017 CPL Physicians — All Rights Reserved
Linked In Twitter Google
Back to Top